A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Penumbra Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 5,789 shares of PEN stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,789
Previous 19,402 70.16%
Holding current value
$1.39 Million
Previous $3.49 Million 67.83%
% of portfolio
0.01%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.64 - $210.12 $2.23 Million - $2.86 Million
-13,613 Reduced 70.16%
5,789 $1.12 Million
Q2 2024

Aug 14, 2024

SELL
$172.27 - $223.95 $165,723 - $215,439
-962 Reduced 4.72%
19,402 $3.49 Million
Q1 2024

May 14, 2024

SELL
$220.09 - $273.15 $4.09 Million - $5.07 Million
-18,577 Reduced 47.71%
20,364 $4.54 Million
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $3.96 Million - $5.67 Million
21,800 Added 127.18%
38,941 $9.8 Million
Q3 2023

Nov 13, 2023

SELL
$240.69 - $338.77 $5.59 Million - $7.87 Million
-23,241 Reduced 57.55%
17,141 $4.15 Million
Q2 2023

Aug 11, 2023

SELL
$271.54 - $344.06 $1.08 Million - $1.37 Million
-3,993 Reduced 9.0%
40,382 $13.9 Million
Q1 2023

May 12, 2023

SELL
$220.43 - $278.69 $50,037 - $63,262
-227 Reduced 0.51%
44,375 $12.4 Million
Q4 2022

Feb 13, 2023

SELL
$151.88 - $228.5 $2.11 Million - $3.18 Million
-13,909 Reduced 23.77%
44,602 $9.91 Million
Q3 2022

Nov 10, 2022

SELL
$120.36 - $205.88 $69,327 - $118,586
-576 Reduced 0.97%
58,511 $11.1 Million
Q2 2022

Aug 11, 2022

BUY
$116.09 - $227.33 $685,163 - $1.34 Million
5,902 Added 11.1%
59,087 $7.36 Million
Q1 2022

May 13, 2022

BUY
$187.51 - $283.98 $2.72 Million - $4.12 Million
14,524 Added 37.57%
53,185 $11.8 Million
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $516,633 - $624,960
2,170 Added 5.95%
38,661 $11.1 Million
Q3 2021

Nov 12, 2021

SELL
$250.72 - $291.24 $384,855 - $447,053
-1,535 Reduced 4.04%
36,491 $9.73 Million
Q2 2021

Aug 13, 2021

BUY
$235.0 - $310.7 $3.75 Million - $4.96 Million
15,977 Added 72.46%
38,026 $10.4 Million
Q1 2021

May 14, 2021

BUY
$175.6 - $291.43 $170,507 - $282,978
971 Added 4.61%
22,049 $5.97 Million
Q4 2020

Feb 12, 2021

BUY
$174.98 - $272.83 $2.21 Million - $3.45 Million
12,637 Added 149.71%
21,078 $3.69 Million
Q3 2020

Nov 13, 2020

BUY
$185.27 - $238.73 $1.56 Million - $2.02 Million
8,441 New
8,441 $1.64 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.